U-Neuron Biomedical

U-Neuron Biomedical FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of U-Neuron Biomedical (6973.TWO) as of Oct 11, 2026 is 164.73 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 65.49 % — a change of 151.51% (higher).

FCF Conversion

164.73 %

YoY

151.51%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of U-Neuron Biomedical is 2024 164.73 % . FCF Conversion Rate (FCF/EBITDA) of U-Neuron Biomedical was 2023 65.49 % . It decreases by 151.51% higher compared to the previous year.

The U-Neuron Biomedical FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2021
22.31 TWD
Jan 1, 2022
92.07 TWD
Jan 1, 2023
65.49 TWD
Jan 1, 2024
164.73 TWD
The U-Neuron Biomedical FCF Conversion history
YEARFCF ConversionYoY
164.73 %+151.51%
65.49 %-28.87%
92.07 %+312.64%
22.31 %—
Access this data via the Eulerpool API
Get Free API Key

U-Neuron Biomedical Stock analysis

What does U-Neuron Biomedical do? U-Neuron Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about U-Neuron Biomedical stock

FCF Conversion Rate (FCF/EBITDA) of U-Neuron Biomedical is 164.73 % in 2024.

FCF Conversion Rate (FCF/EBITDA) of U-Neuron Biomedical changed from 65.49 % to 164.73 %, representing a 151.51% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) U-Neuron Biomedical since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s U-Neuron Biomedical with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API
Get Free API Key

Cash Flow — U-Neuron Biomedical

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — U-Neuron Biomedical